2 ms·
The statistics actually come from the esteemed British medical journal Lancet. Google it; the over-performance of the US across a broad swath of cancers in that
by jandrewrogers 14y ago
The statistics actually come from the esteemed British medical journal Lancet. Google it; the over-performance of the US across a broad swath of cancers in that study attracted a lot of attention.
As for why the US has better treatments, depending on how you measure it, 70-80% of all new biomedical R&D globally is done in the US. Consequently, if there is a new biomedical technology, it shows up in the US system first where they can capture the R&D investment. Most of the rest of the R&D is done in Asia.
You are correct about one thing: the US has extremely high levels of diagnostic testing compared to the rest of the developed world. It is both part of the cost and also why survival rates are higher for many diseases. The survival rates are not just better treatments, it is also earlier diagnosis by virtue of heavy use of (expensive) diagnostic tests.